Effect of p-chlorophenylalanine on diazepam withdrawal signs in rats. 1980

T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa

The effect of p-chlorophenylalanine (PCPA), a specific serotonin (5-HT) depleter, on diazepam withdrawal signs was studied. Rats were made dependent on diazepam by the chronic administration of this drug in the diet. At the time of diazepam withdrawal, the animals were treated with PCPA (200 mg/kg, IP) or the corresponding vehicle (control). After diazepam withdrawal, the maximal body weight losses of control and PCPA-treated animals were 4.1% and 9.0%, respectively. In naive animals, PCPA did not cause any change in body weight. These results suggest that depletion of central 5-HT by PCPA may potentiate the severity of diazepam withdrawal signs.

UI MeSH Term Description Entries
D008297 Male Males
D010134 Fenclonine A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin. p-Chlorophenylalanine,para-Chlorophenylalanine,CP-10,188,DL-3-(4-Chlorophenyl)alanine,Fenclonin,Fenclonine (L)-Isomer,Fenclonine Hydrobromide,Fenclonine Hydrochloride,Fenclonine, (D)-Isomer,Hydrobromide, Fenclonine,Hydrochloride, Fenclonine,para Chlorophenylalanine
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
February 1983, The American journal of physiology,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
August 1970, Brain research,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
June 1974, British journal of pharmacology,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
May 1969, British journal of pharmacology,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
March 1974, Quarterly journal of studies on alcohol,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
February 1987, Indian journal of experimental biology,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
July 1970, Journal of reproduction and fertility,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
February 1971, Science (New York, N.Y.),
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
November 1972, Molecular pharmacology,
T Suzuki, and R Fukumori, and T Yoshii, and S Yanaura, and T Satoh, and H Kitagawa
January 1992, Brain research,
Copied contents to your clipboard!